Restoring the physiology of natural healing

Novadip is designing new treatment options for critical size defects, complex small size defects and surgically inaccessible tissue with its patented 3D tissue regeneration technology platform to transform the lives of patients with unmet medical needs.

Like Comment
Page of
Go to the profile of Novadip

Novadip

CEO, Novadip

Based on the scientific discoveries of Prof. Dr. Denis Dufrane, Novadip is a spin-off company from Université Catholique de Louvain (UCLouvain) and St. Luc University Hospital. The creation of Novadip was supported by the Louvain Technology Transfer Office (LTTO), Sopartec and VIVES II. Using our unique 3M3 tissue regeneration platform, which utilizes adipose-derived stem cells within a 3-dimensional extracellular matrix, to drive multiple product classes, Novadip’s mission is to provide innovative solutions for patients with limited or no effective treatment options.

No comments yet.